Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1247386

	registered interest
	date	30/10/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether people who live in the same home as people who are clinically extremely vulnerable will receive a vaccine for covid-19 before the rest of the general public.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	109297
	answer	answer is ministerial correction date of answer 18/11/2020 answer text <p>Whilst there is a desire for the whole United Kingdom population to be vaccinated, there may need to be an element of prioritisation based on vaccine supply, availability and evidence as data emerges from clinical trials on safety and efficacy in different cohorts of the population.</p><p>The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who provide advice to Government on which vaccine(s) the UK should use and which groups within the population to prioritise. The JCVI and the JCVI sub-committee are currently reviewing evidence on clinical risk factors associated with serious disease and mortality from COVID-19. Following a review of the evidence, the Committee will develop advice on risk groups for any future COVID-19 vaccination programme.</p><p>The latest JCVI recommendations on the priority groups for a COVID-19 vaccine is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020" target="_blank">https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-25-september-2020</a></p><p>The minutes of JCVI committee meetings and statements on COVID-19 vaccination are available at the following link:</p><p><a href="https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation" target="_blank">https://www.gov.uk/government/groups/joint-committee-on-vaccination-and-immunisation</a></p><p><strong> </strong></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 18/11/2020 13:04:24 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1378075

	registered interest
	date	12/11/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to empower clinicians to prescribe medicinal cannabis; and if he will make a statement.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	73803
	answer	answer is ministerial correction date of answer 18/11/2021 answer text <p>Whether to prescribe any medicine is a clinical decision and the Government has enabled the prescription of cannabis-based products for medicinal use where it is clinically appropriate. The Chief Medical Officer and NHS England have written to doctors and pharmacists to highlight the available guidance on the prescribing and use of unlicensed medicines and to clarify the procedure for prescribing and supplying cannabis-based products for medicinal use. Health Education England has also published an e-learning module on medicinal cannabis.</p><p>The licensed cannabis-based medicine Epidyolex is prescribed and routinely funded by the National Health Service for Dravet syndrome and Lennox-Gastaut syndrome. The Medicines and Healthcare products Regulatory Agency has recently approved Epidyolex for a third form of epilepsy and it is now being assessed by the National Institute for Health and Care Excellence (NICE) for this indication. The licensed medicine Sativex is also routinely funded to treat moderate to severe spasticity in adults with multiple sclerosis. On 6 September, NHS England issued a reminder to clinical commissioning groups of NICE’s guidance relating to Sativex and will be monitoring its uptake.</p><p>The latest NICE guidelines demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based products on the NHS. The Government continues to support the establishment of clinical trials with NHS England and NHS Improvement and the National Institute for Health Research and from 1 April introduced a national patient registry to record patient outcomes. Since January 2020, the Refractory Epilepsy Specialist Clinical Advisory Service has been in place to provide advice and support for doctors to optimise the treatment of refractory epilepsy.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 73766 73767 73768 73769 question first answered 18/11/2021 10:20:44 answering member 4362 label Biography information for Edward Argar
	tabling member	3960 label Biography information for Henry Smith

1289683

	registered interest
	date	24/02/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cutaneous T-cell Lymphoma: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the UK Rare Disease Framework, what steps he plans to take to engage with the rare blood cancer community to improve care coordination for people living with mycosis fungoides and Sézary syndrome, two subtypes of Cutaneous T-Cell Lymphoma, a rare blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	158006
	answer	answer is ministerial correction date of answer 17/03/2021 answer text <p>We will continue to engage with a range of stakeholders, including the rare blood cancer community, before publishing action plans that outline how the priorities and underlying themes in the Framework will be addressed.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 17/03/2021 15:18:14 answering member 4380 label Biography information for Jo Churchill
	tabling member	3960 label Biography information for Henry Smith

1293344

	registered interest
	date	01/03/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of covid-19 vaccination uptake among clinically extremely vulnerable people, by disease or condition.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	160625
	answer	answer is ministerial correction date of answer 17/03/2021 answer text <p>We have made no such estimate as data is not collected in that format.</p><p> </p><p>Weekly updates are published on the number of first and second dose vaccinations in England to clinically extremely vulnerable (CEV) patients covering cumulative totals, numbers identified as CEV and the percentage of CEV people who have received at least one dose. The data is available at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/" target="_blank">https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-vaccinations/</a></p> answering member constituency Stratford-on-Avon answering member printed Nadhim Zahawi question first answered 17/03/2021 12:50:29 answering member 4113 label Biography information for Nadhim Zahawi
	tabling member	3960 label Biography information for Henry Smith

982661

	registered interest
	date	08/10/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Blood Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many blood cancer patients have received medicine funded by the Cancer Drugs Fund by each medicine since 2016.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	176228
	answer	answer is ministerial correction date of answer 16/10/2018 answer text <p>We have been informed by NHS England that since the implementation of the new Cancer Drugs Fund on 29 July 2016, 7,821 patients have been registered to receive treatment for a blood cancer, out of a total of approximately 25,700 patients who have been registered to receive cancer drug treatment. NHS England has advised that it is unable to provide a breakdown of patients registered to receive treatment with each medicine for reasons of commercial confidentiality.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 16/10/2018 16:10:46 answering member 4067 label Biography information for Steve Brine
	tabling member	3960 label Biography information for Henry Smith

1541364

	registered interest
	date	09/11/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Suicide: Veterans
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will take steps to encourage local authorities to increase their engagement with veterans charities to help inform local authority suicide prevention action plans.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	83604
	answer	answer is ministerial correction date of answer 15/11/2022 answer text <p>We continue to work with local authorities to ensure that suicide prevention action plans remain effective and include at-risk groups, such as veterans.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 15/11/2022 17:17:36 answering member 4492 label Biography information for Maria Caulfield
	tabling member	3960 label Biography information for Henry Smith

1452241

	registered interest
	date	17/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, in the context of the Conditional Marketing Authorisation awarded by the Medicines and Healthcare products Regulatory Agencyon 17 March 2022, what plans he has to (a) procure Evusheld and (b) roll out the treatment to severely immunocompromised patients.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	141958
	answer	answer is ministerial correction date of answer 28/03/2022 answer text <p>We are unable to provide the information requested as this is commercially sensitive. Any public announcement would be made after an agreement is reached with companies.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 141960 question first answered 28/03/2022 14:35:47 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1452245

	registered interest
	date	17/03/2022
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Evusheld
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many doses of the MHRA approved Evusheld covid-19 preventative treatment for immunocompromised patients his Department plans to procure; and when he expects to outline eligibility to receive this treatment.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	141960
	answer	answer is ministerial correction date of answer 28/03/2022 answer text <p>We are unable to provide the information requested as this is commercially sensitive. Any public announcement would be made after an agreement is reached with companies.</p><p> </p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 141958 question first answered 28/03/2022 14:35:47 answering member 4447 label Biography information for Maggie Throup
	tabling member	3960 label Biography information for Henry Smith

1316286

	registered interest
	date	19/05/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Motor Neurone Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support targeted research on motor neurone disease.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	3840
	answer	answer is ministerial correction date of answer 27/05/2021 answer text <p>We are currently working on ways to significantly boost further research on dementia and neurodegeneration. On 29 April, I hosted a roundtable event on boosting motor neurone disease research with the National Institute for Health Research Sheffield Biomedical Research Centre. The event brought together researchers, charities, people with motor neurone disease and funders. We will be working closely with these stakeholders over the coming months to consider ways forward for this vital area of research.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/05/2021 16:57:56 answering member 4527 label Biography information for Helen Whately
	tabling member	3960 label Biography information for Henry Smith

1105983

	registered interest
	date	28/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Cancer: Health Education
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential merits of including in the Green Paper on prevention, a skin cancer awareness porgramme.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	238324
	answer	answer is ministerial correction date of answer 04/04/2019 answer text <p>We are considering a number of policy options for the prevention Green Paper and will be mindful of the suggestion of a skin cancer awareness campaign.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 04/04/2019 14:49:12 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	3960 label Biography information for Henry Smith